129 related articles for article (PubMed ID: 36265182)
1. NCAPG2 contributes to the progression of malignant melanoma through regulating proliferation and metastasis.
Feng Z; Zhang L; Liu Y; Zhang W
Biochem Cell Biol; 2022 Dec; 100(6):473-484. PubMed ID: 36265182
[TBL] [Abstract][Full Text] [Related]
2. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
3. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract][Full Text] [Related]
4. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
[TBL] [Abstract][Full Text] [Related]
5. microRNA-375 inhibits the malignant behaviors of hepatic carcinoma cells by targeting NCAPG2.
Dai HT; Wang ST; Chen B; Tang KY; Li N; Wen CY; Wan Y; Zhang GY; Huang YH; Geng ZJ
Neoplasma; 2022 Jan; 69(1):16-27. PubMed ID: 34818025
[TBL] [Abstract][Full Text] [Related]
6. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
7. The mRNA stability of NCAPG2, a novel contributor to breast invasive carcinoma, is enhanced by the RNA-binding protein PCBP2.
Han S; Jin X; Hu T; Chi F
Cell Signal; 2023 Oct; 110():110844. PubMed ID: 37544634
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
9. Search for novel STAT3-dependent genes reveals SERPINA3 as a new STAT3 target that regulates invasion of human melanoma cells.
Kulesza DW; Ramji K; Maleszewska M; Mieczkowski J; Dabrowski M; Chouaib S; Kaminska B
Lab Invest; 2019 Nov; 99(11):1607-1621. PubMed ID: 31278347
[TBL] [Abstract][Full Text] [Related]
10. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
[TBL] [Abstract][Full Text] [Related]
11. STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway.
Wang Y; Lou N; Zuo M; Zhu F; He Y; Cheng Z; Wang X
RNA Biol; 2021 Oct; 18(sup1):355-368. PubMed ID: 34241580
[TBL] [Abstract][Full Text] [Related]
12. Brachyury promotes proliferation and migration of hepatocellular carcinoma via facilitating the transcription of NCAPG2.
Li S; Lu Y; Xu Y; Zhang C; Liu B; Qin A; Qiao Z; Shen C; Shen J; Liang Y; Wu J; Jiang X
Am J Cancer Res; 2022; 12(8):3625-3643. PubMed ID: 36119840
[TBL] [Abstract][Full Text] [Related]
13. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.
Pan J; Ruan W; Qin M; Long Y; Wan T; Yu K; Zhai Y; Wu C; Xu Y
Sci Rep; 2018 Jan; 8(1):1117. PubMed ID: 29348670
[TBL] [Abstract][Full Text] [Related]
14. Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis.
Zhao F; Jia Z; Feng Y; Li Z; Feng J
J Dermatol Sci; 2021 Apr; 102(1):7-15. PubMed ID: 33648800
[TBL] [Abstract][Full Text] [Related]
16. Pseudopodium enriched atypical kinase 1(PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals.
Pan M; Yin X; Huang YC
Bioengineered; 2021 Dec; 12(1):5045-5055. PubMed ID: 34365903
[TBL] [Abstract][Full Text] [Related]
17. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.
Kulesza DW; Przanowski P; Kaminska B
Cell Biol Int; 2019 Jun; 43(6):613-622. PubMed ID: 30958597
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
